In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.
The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at CAD 0.13 CAD in weekly data.
As regards fundamentals, the enterprise value to sales ratio is at 0.97 for the current period. Therefore, the company is undervalued.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
The stock is close to a major daily resistance at CAD 0.21, which should be gotten rid of so as to gain new appreciation potential.
According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
The group usually releases earnings worse than estimated.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
Below the resistance at 0.48 CAD, the stock shows a negative configuration when looking looking at the weekly chart.